Skip to main content
INCR
NASDAQ Life Sciences

Intercure Faces Nasdaq Delisting Threat Amidst Major Lawsuits and Operational Challenges

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.84
Mkt Cap
$46.025M
52W Low
$0.68
52W High
$1.77
52W Position info
24% above low
Off High info
53% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

INCR sits 24% above its 52-week low of $0.68.

Summary

Intercure Ltd. reported improved 2025 financial results but disclosed a Nasdaq minimum bid price non-compliance notice and is a defendant in multiple material lawsuits, including a NIS 420 million class action.


Key Events · Legal and Risk Events · INCR

  • Nasdaq Delisting Notice Received

    The company received a notice on February 25, 2026, from Nasdaq for non-compliance with the $1.00 minimum bid price rule, with a deadline of August 24, 2026, to regain compliance.

  • Major Class Action Lawsuit

    Intercure is a defendant in a class action lawsuit seeking NIS 420 million (approximately $115 million USD) for alleged unlawful advertising of medical cannabis, with a trial scheduled for November 2026.

  • Improved 2025 Financial Performance

    Reported NIS 270 million in revenue for 2025, a 13% increase from 2024, and a reduced net loss of NIS 37 million (compared to NIS 73 million in 2024), alongside positive cash flow from operations of NIS 17 million.

  • Southern Facility Restoration and War Compensation

    Restoration of the Southern Facility, severely damaged in the October 2023 attacks, is ongoing, and the company has received NIS 82 million in advance compensation payments from Israeli authorities.


Analysis · INCR · Life Sciences

This annual report reveals significant risks that overshadow the company's improved financial performance. The Nasdaq delisting notice poses an immediate threat to the company's public trading status and ability to raise capital. Furthermore, the company is embroiled in several material legal disputes, most notably a class action lawsuit seeking NIS 420 million (approximately $115 million USD), which is substantial relative to its market capitalization. Operational challenges, including the ongoing restoration of its Southern Facility due to war damage and the termination of several international partnerships, add to the uncertainty. Investors should closely monitor the Nasdaq compliance efforts and the outcomes of the various legal proceedings.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INCR was trading at $0.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $46M. The 52-week trading range was $0.68 to $1.77. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INCR - Latest Insights

INCR
Sep 08, 2026, 4:13 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.39
Real-time Price: $3.24 info
Change: -$2.15 (-40%) info
Market Cap: $42.032M info
INCR
Aug 27, 2026, 11:38 AM EDT
Filing Type: 6-K/A
Importance Score:
7
Price at Filing: $5.74
Real-time Price: $3.24 info
Change: -$2.50 (-44%) info
Market Cap: $42.032M info
INCR
Aug 26, 2026, 4:06 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.85
Real-time Price: $3.24 info
Change: -$2.61 (-45%) info
Market Cap: $42.032M info
INCR
Aug 24, 2026, 7:05 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.15
Real-time Price: $3.24 info
Change: Reverse Stock Split info
Market Cap: $42.032M info
INCR
Aug 24, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.15
Real-time Price: $3.24 info
Change: Reverse Stock Split info
Market Cap: $42.032M info